160 related articles for article (PubMed ID: 35179533)
1. Delivery of siRNA based on engineered exosomes for glioblastoma therapy by targeting STAT3.
Liang SF; Zuo FF; Yin BC; Ye BC
Biomater Sci; 2022 Mar; 10(6):1582-1590. PubMed ID: 35179533
[TBL] [Abstract][Full Text] [Related]
2. Single siRNA Nanocapsules for Effective siRNA Brain Delivery and Glioblastoma Treatment.
Zou Y; Sun X; Wang Y; Yan C; Liu Y; Li J; Zhang D; Zheng M; Chung RS; Shi B
Adv Mater; 2020 Jun; 32(24):e2000416. PubMed ID: 32374446
[TBL] [Abstract][Full Text] [Related]
3. Cation-Free siRNA Micelles as Effective Drug Delivery Platform and Potent RNAi Nanomedicines for Glioblastoma Therapy.
Jiang T; Qiao Y; Ruan W; Zhang D; Yang Q; Wang G; Chen Q; Zhu F; Yin J; Zou Y; Qian R; Zheng M; Shi B
Adv Mater; 2021 Nov; 33(45):e2104779. PubMed ID: 34751990
[TBL] [Abstract][Full Text] [Related]
4. Membrane-Decorated Exosomes for Combination Drug Delivery and Improved Glioma Therapy.
Liang S; Xu H; Ye BC
Langmuir; 2022 Jan; 38(1):299-308. PubMed ID: 34936368
[TBL] [Abstract][Full Text] [Related]
5. Dual-targeting immunoliposomes using angiopep-2 and CD133 antibody for glioblastoma stem cells.
Kim JS; Shin DH; Kim JS
J Control Release; 2018 Jan; 269():245-257. PubMed ID: 29162480
[TBL] [Abstract][Full Text] [Related]
6. T7 peptide-decorated exosome-based nanocarrier system for delivery of Galectin-9 siRNA to stimulate macrophage repolarization in glioblastoma.
Li C; Guan N; Liu F
J Neurooncol; 2023 Mar; 162(1):93-108. PubMed ID: 36854924
[TBL] [Abstract][Full Text] [Related]
7. Charge Conversional Biomimetic Nanocomplexes as a Multifunctional Platform for Boosting Orthotopic Glioblastoma RNAi Therapy.
Liu Y; Zou Y; Feng C; Lee A; Yin J; Chung R; Park JB; Rizos H; Tao W; Zheng M; Farokhzad OC; Shi B
Nano Lett; 2020 Mar; 20(3):1637-1646. PubMed ID: 32013452
[TBL] [Abstract][Full Text] [Related]
8. ROS-Responsive Polymeric siRNA Nanomedicine Stabilized by Triple Interactions for the Robust Glioblastoma Combinational RNAi Therapy.
Zheng M; Liu Y; Wang Y; Zhang D; Zou Y; Ruan W; Yin J; Tao W; Park JB; Shi B
Adv Mater; 2019 Sep; 31(37):e1903277. PubMed ID: 31348581
[TBL] [Abstract][Full Text] [Related]
9. Small interfering RNA (siRNA) to target genes and molecular pathways in glioblastoma therapy: Current status with an emphasis on delivery systems.
Mirzaei S; Mahabady MK; Zabolian A; Abbaspour A; Fallahzadeh P; Noori M; Hashemi F; Hushmandi K; Daneshi S; Kumar AP; Aref AR; Samarghandian S; Makvandi P; Khan H; Hamblin MR; Ashrafizadeh M; Zarrabi A
Life Sci; 2021 Jun; 275():119368. PubMed ID: 33741417
[TBL] [Abstract][Full Text] [Related]
10. Blood exosomes-based targeted delivery of cPLA2 siRNA and metformin to modulate glioblastoma energy metabolism for tailoring personalized therapy.
Zhan Q; Yi K; Cui X; Li X; Yang S; Wang Q; Fang C; Tan Y; Li L; Xu C; Yuan X; Kang C
Neuro Oncol; 2022 Nov; 24(11):1871-1883. PubMed ID: 35312010
[TBL] [Abstract][Full Text] [Related]
11. Multifunctional exosome-mimetics for targeted anti-glioblastoma therapy by manipulating protein corona.
Wu JY; Li YJ; Wang J; Hu XB; Huang S; Luo S; Xiang DX
J Nanobiotechnology; 2021 Dec; 19(1):405. PubMed ID: 34872569
[TBL] [Abstract][Full Text] [Related]
12. Systemic brain tumor delivery of synthetic protein nanoparticles for glioblastoma therapy.
Gregory JV; Kadiyala P; Doherty R; Cadena M; Habeel S; Ruoslahti E; Lowenstein PR; Castro MG; Lahann J
Nat Commun; 2020 Nov; 11(1):5687. PubMed ID: 33173024
[TBL] [Abstract][Full Text] [Related]
13. A Preclinical Investigation of GBM-N019 as a Potential Inhibitor of Glioblastoma via Exosomal mTOR/CDK6/STAT3 Signaling.
Wu ATH; Huang HS; Wen YT; Lawal B; Mokgautsi N; Huynh TT; Hsiao M; Wei L
Cells; 2021 Sep; 10(9):. PubMed ID: 34572040
[TBL] [Abstract][Full Text] [Related]
14. Synchronous Disintegration of Ferroptosis Defense Axis via Engineered Exosome-Conjugated Magnetic Nanoparticles for Glioblastoma Therapy.
Li B; Chen X; Qiu W; Zhao R; Duan J; Zhang S; Pan Z; Zhao S; Guo Q; Qi Y; Wang W; Deng L; Ni S; Sang Y; Xue H; Liu H; Li G
Adv Sci (Weinh); 2022 Jun; 9(17):e2105451. PubMed ID: 35508804
[TBL] [Abstract][Full Text] [Related]
15. Immune Exosomes Loading Self-Assembled Nanomicelles Traverse the Blood-Brain Barrier for Chemo-immunotherapy against Glioblastoma.
Cui J; Wang X; Li J; Zhu A; Du Y; Zeng W; Guo Y; Di L; Wang R
ACS Nano; 2023 Jan; ():. PubMed ID: 36626296
[TBL] [Abstract][Full Text] [Related]
16. JAK2/STAT3 targeted therapy suppresses tumor invasion via disruption of the EGFRvIII/JAK2/STAT3 axis and associated focal adhesion in EGFRvIII-expressing glioblastoma.
Zheng Q; Han L; Dong Y; Tian J; Huang W; Liu Z; Jia X; Jiang T; Zhang J; Li X; Kang C; Ren H
Neuro Oncol; 2014 Sep; 16(9):1229-43. PubMed ID: 24861878
[TBL] [Abstract][Full Text] [Related]
17. Kill two birds with one stone: Engineered exosome-mediated delivery of cholesterol modified YY1-siRNA enhances chemoradiotherapy sensitivity of glioblastoma.
Liu X; Cao Z; Liu N; Gao G; Du M; Wang Y; Cheng B; Zhu M; Jia B; Pan L; Zhang W; Jiang Y; He W; Xu L; Zhang W; An Q; Guo Q; Gu J
Front Pharmacol; 2022; 13():975291. PubMed ID: 36059990
[TBL] [Abstract][Full Text] [Related]
18. On-target JAK2/STAT3 inhibition slows disease progression in orthotopic xenografts of human glioblastoma brain tumor stem cells.
Stechishin OD; Luchman HA; Ruan Y; Blough MD; Nguyen SA; Kelly JJ; Cairncross JG; Weiss S
Neuro Oncol; 2013 Feb; 15(2):198-207. PubMed ID: 23262510
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic targeting of STAT3 with small interference RNAs and antisense oligonucleotides embedded exosomes in liver fibrosis.
Tang M; Chen Y; Li B; Sugimoto H; Yang S; Yang C; LeBleu VS; McAndrews KM; Kalluri R
FASEB J; 2021 May; 35(5):e21557. PubMed ID: 33855751
[TBL] [Abstract][Full Text] [Related]
20. Synergistic effect of STAT3‑targeted small interfering RNA and AZD0530 against glioblastoma in vitro and in vivo.
Liu Q; Wang L; Li D; Zhao J; Chen S; Li J
Mol Med Rep; 2019 Oct; 20(4):3625-3632. PubMed ID: 31485668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]